Abstract:A self‐crosslinkable and multifunctional polymer‐based matrix microneedle (mMN) patch is developed, which is capable of stabilizing highly concentrated insulin and delivering insulin on demand as demonstrated by in vitro analyses and in vivo efficacy studies. The introduced crosslinking strategy eliminates conventionally used harsh conditions for making crosslinked microneedle (MN) patches and thus enables patch fabrication with encapsulated susceptible protein in one step. A transdermal patch that delivers insulin at high glucose concentrations can offer tremendous advantages to ease the concern of safety and improve the quality of life for people with diabetes. Herein, a novel self‐crosslinkable and glucose‐responsive polymer‐based microneedle patch (MN) is designed to deliver insulin at hyperglycemia. The microneedle patch is made of hyaluronic acid polymers functionalized with dopamine and 4‐amino‐3‐fluorophenylboronic acid (AFBA) that can be quickly crosslinked upon mixing of the polymer solutions in the absence of any chemicalcrosslinking agents or organic solvents. The catechol groups in the dopamine (DA) units form covalent crosslinkages among themselves by auto‐oxidation and dynamic crosslink with phenylboronic acid (PBA) via complexation. The reversible crosslinkages between catechol and boronate decrease with increasing glucose concentration leading to higher swelling and faster insulin release at hyperglycemia as compared to euglycemia. Such superior glucose‐responsive properties are demonstrated by in vitro analyses and in vivo efficacy studies. The hydrogel polymers also preserve native structure and bioactivity of insulin, attributable to the interaction of hyaluronic acid (HA) with insulin molecules, as revealed by experiments and molecular dynamics simulations. The simplicity in the design and fabrication process, and glucose‐responsiveness in insulin delivery impart the matrix microneedle (mMN) patch great potential for clinical translation.

Polypyrrole-Based Implantable Electroactive Pump For Controlled Drug Microinjection

Wireless, Battery-Free and Wearable Device for Electrically Controlled Drug Delivery: Sodium Salicylate Released from Bilayer Polypyrrole by Near-Field Communication on Smartphone.

Electrically controlled release of insulin using polypyrrole nanoparticles

Hydrogel-reinforced Polypyrrole Electroactuator.

Enzymatically stable, non-cell adhesive, implantable polypyrrole/thiolated hyaluronic acid bioelectrodes for in vivo signal recording

A Microfluidic Ion Pump for In Vivo Drug Delivery

Flexible Organic Electronic Ion Pump Fabricated Using Inkjet Printing and Microfabrication for Precision In Vitro Delivery of Bupivacaine

Enhanced Flexible Tubular Microelectrode with Conducting Polymer for Multi-Functional Implantable Tissue-Machine Interface

Self‐Powered Syringe Pump for Insulin Pump Therapy Based on High‐Voltage Triboelectric Nanogenerator and Dielectric Elastomer Actuator

Controlled Transdermal Iontophoresis of Insulin from Water-Soluble Polypyrrole Nanoparticles: An In Vitro Study

Controlled Bioactive Delivery Using Degradable Electroactive Polymers

Functionalized gold nanoparticle-polypyrrole nanobiocomposite with high effective surface area for electrochemical/pH dual stimuli-responsive smart release of insulin

A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules

An Intelligent Wearable Artificial Pancreas Patch Based on a Microtube Glucose Sensor and an Ultrasonic Insulin Pump

A wearable, rapidly manufacturable, stability-enhancing microneedle patch for closed-loop diabetes management

Intelligent Microneedle Patch Based on Functionalized Alginate and Chitosan for Long-Term Self-Regulated Insulin Delivery

Multilayer track‐etched membrane‐based electroosmotic pump for drug delivery

An eco-friendly, biocompatible and reliable piezoelectric nanocomposite actuator for the new generation of microelectronic devices

Drug delivery via a 3D electro-swellable conjugated polymer hydrogel

"Smart" Matrix Microneedle Patch Made of Self‐Crosslinkable and Multifunctional Polymers for Delivering Insulin On‐Demand

Implantable Electronic Medicine Enabled by Bioresorbable Microneedles for Wireless Electrotherapy and Drug Delivery.